| pubmed-article:19014870 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C0717758 | lld:lifeskim |
| pubmed-article:19014870 | lifeskim:mentions | umls-concept:C2895206 | lld:lifeskim |
| pubmed-article:19014870 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19014870 | pubmed:dateCreated | 2008-11-18 | lld:pubmed |
| pubmed-article:19014870 | pubmed:abstractText | To describe the clinical and immunologic features of 6 patients with rheumatic disease and Hepatitis C Virus (HCV) chronic infection, treated with anti-TNF alpha drugs. | lld:pubmed |
| pubmed-article:19014870 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19014870 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19014870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014870 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19014870 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19014870 | pubmed:issn | 1873-0183 | lld:pubmed |
| pubmed-article:19014870 | pubmed:author | pubmed-author:CattaneoRR | lld:pubmed |
| pubmed-article:19014870 | pubmed:author | pubmed-author:FranceschiniF... | lld:pubmed |
| pubmed-article:19014870 | pubmed:author | pubmed-author:CeribelliAA | lld:pubmed |
| pubmed-article:19014870 | pubmed:author | pubmed-author:CavazzanaII | lld:pubmed |
| pubmed-article:19014870 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19014870 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:19014870 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19014870 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19014870 | pubmed:pagination | 104-6 | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:meshHeading | pubmed-meshheading:19014870... | lld:pubmed |
| pubmed-article:19014870 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19014870 | pubmed:articleTitle | Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. | lld:pubmed |
| pubmed-article:19014870 | pubmed:affiliation | Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy. ilariacava@virgilio.it | lld:pubmed |
| pubmed-article:19014870 | pubmed:publicationType | Journal Article | lld:pubmed |
